L³ is LongGame Ventures' early-stage investment launchpad designed to identify and accelerate high-potential longevity companies globally. We combine:
This is not an accelerator. It is an investment-first selection program designed to surface and support the next generation of category-defining longevity companies.
Focus areas:
Science-Backed Consumer Tech
Longevity Biomarkers & Proprietary Data
Breakthrough Partial Reprogramming
👉 Selected companies may be considered for investment from a total pool of up to $2M.
July 1
Applications open
July – August
Review, founder calls, diligence
Mid September
Demo Day (virtual)
September onward
Investment decisions & syndication support
Exceptional companies may be engaged earlier as diligence progresses.
We work with founders who are:
Building science-driven or technically differentiated companies
Operating at Pre-Seed to Seed stage
Creating defensible technology, data, or IP
Focused on measurable impact in healthspan or longevity
Ready to engage in early-stage fundraising or acceleration
We are especially interested in founders pushing the boundaries of what is possible in human health.
Scientific or technical innovation
Defensibility (IP, data, or infrastructure)
Strength of founding team
Market potential and scalability
Financing readiness and momentum
Selected founders will present at a curated demo day attended by:
Investors
Longevity KOLs and scientists
Strategic ecosystem partners
The goal is not just visibility but momentum.
We actively support syndication pathways and financing conversations following the event.
Apply Now
Applications are OPEN!
If you are building in:
Partial Reprogramming
Proprietary Data x AI for aging
Science-Backed Consumer